Dr Heidi Elizabeth Fleischmann, MD | |
7520 Montgomery Blvd Ne, Bldg D4, Albuquerque, NM 87109-1533 | |
(505) 884-7070 | |
(505) 884-6018 |
Full Name | Dr Heidi Elizabeth Fleischmann |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 7520 Montgomery Blvd Ne, Albuquerque, New Mexico |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063473403 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207N00000X | Dermatology | 87-233 (New Mexico) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Heidi Elizabeth Fleischmann, MD 7520 Montgomery Blvd Ne, Bldg D4, Albuquerque, NM 87109-1533 Ph: (505) 884-7070 | Dr Heidi Elizabeth Fleischmann, MD 7520 Montgomery Blvd Ne, Bldg D4, Albuquerque, NM 87109-1533 Ph: (505) 884-7070 |
News Archive
Congenital rubella syndrome, a birth defect caused by the rubella virus (also known as German measles), has practically been eliminated in the U.S., according to a statement published in the April 2006 issue of Birth Defects Research Part A, the official journal of The Teratology Society.
BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.
Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration has approved Opdivo in combination with Yervoy for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive unresectable or metastatic melanoma.
Achillion Pharmaceuticals, Inc., a leader in the discovery and development of treatments for the most challenging infectious diseases, today announced that its abstract titled "Virological Response, Safety, and Pharmacokinetic Profile Following Single- and Multiple-Dose Administration of ACH-0141625 Protease Inhibitor to Healthy Volunteers and HCV Genotype-1 Patients" has been accepted as a late breaking poster presentation at the International Liver Congress™ 2010 being held April 14-18 in Vienna, Austria.
› Verified 4 days ago
Dr. Willliam F Willis, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Albuquerque, NM 87109 Phone: 505-884-7070 Fax: 505-884-6018 | |
R. Steven Padilla, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1021 Medical Arts Ave Ne, Albuquerque, NM 87102 Phone: 505-272-4947 | |
Phillip Strange, MD Dermatology Medicare: Medicare Enrolled Practice Location: 1021 Medical Arts Ave Ne, Msc09 4240, Albuquerque, NM 87102 Phone: 505-272-6222 | |
Carol Purcell, PA-C Dermatology Medicare: Accepting Medicare Assignments Practice Location: 10151 Montgomery Blvd Ne Bldg 1, Suite A, Albuquerque, NM 87111 Phone: 505-855-5503 Fax: 505-855-5533 | |
Dr. Emily M Altman, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 933 Bradbury Dr Se Ste 2222, Albuquerque, NM 87106 Phone: 505-272-6000 Fax: 505-272-6228 | |
Shelly Ann Stepenaskie, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1001 Woodward Pl Ne, Albuquerque, NM 87102 Phone: 505-938-8296 Fax: 505-938-8688 |